These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37303863)

  • 1. Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
    Neurooncol Adv; 2023; 5(1):vdad072. PubMed ID: 37303863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
    du Chatinier A; Meel MH; Das AI; Metselaar DS; Waranecki P; Bugiani M; Breur M; Simonds EF; Lu ED; Weiss WA; Garcia Vallejo JJ; Hoving EW; Phoenix TN; Hulleman E
    Neurooncol Adv; 2022; 4(1):vdac079. PubMed ID: 35733514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: This is a corrigendum to: Kumthekar et al, A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac123, https://doi.org/10.1093/noajnl/vdac123.
    Neurooncol Adv; 2023; 5(1):vdad103. PubMed ID: 37664526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to: Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing.
    Neurooncol Adv; 2023; 5(1):vdad005. PubMed ID: 36660081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes.
    Huang T; Garcia R; Qi J; Lulla R; Horbinski C; Behdad A; Wadhwani N; Shilatifard A; James C; Saratsis AM
    Oncotarget; 2019 Apr; 10(28):2788. PubMed ID: 31105875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to: Epigenetic dysregulation in meningiomas.
    Neurooncol Adv; 2023; 5(1):vdac190. PubMed ID: 36632569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
    Chi AS; Tarapore RS; Hall MD; Shonka N; Gardner S; Umemura Y; Sumrall A; Khatib Z; Mueller S; Kline C; Zaky W; Khatua S; Weathers SP; Odia Y; Niazi TN; Daghistani D; Cherrick I; Korones D; Karajannis MA; Kong XT; Minturn J; Waanders A; Arillaga-Romany I; Batchelor T; Wen PY; Merdinger K; Schalop L; Stogniew M; Allen JE; Oster W; Mehta MP
    J Neurooncol; 2019 Oct; 145(1):97-105. PubMed ID: 31456142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes.
    Huang T; Garcia R; Qi J; Lulla R; Horbinski C; Behdad A; Wadhwani N; Shilatifard A; James C; Saratsis AM
    Oncotarget; 2018 Dec; 9(98):37112-37124. PubMed ID: 30647848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to: Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies.
    Neurooncol Adv; 2023; 5(1):vdad019. PubMed ID: 36923271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields.
    Neurooncol Adv; 2022; 4(1):vdac164. PubMed ID: 36325375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.
    Nasir A; Cardall A; Othman RT; Nicolaou N; Lourdusamy A; Linke F; Onion D; Ryzhova M; Cameron H; Valente C; Ritchie A; Korshunov A; Pfister SM; Grabowska AM; Kerr ID; Coyle B
    Neurooncol Adv; 2021; 3(1):vdab155. PubMed ID: 34988447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to: Surgery versus radiosurgery for vestibular schwannoma: Shared decision making in a multidisciplinary clinic.
    Neurooncol Adv; 2024; 6(1):vdae011. PubMed ID: 38312229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
    Butt OH; Zhou AY; Huang J; Leidig WA; Silberstein AE; Chheda MG; Johanns TM; Ansstas G; Liu J; Talcott G; Nakiwala R; Shimony JS; Kim AH; Leuthardt EC; Tran DD; Campian JL
    Neurooncol Adv; 2022; 4(1):vdac042. PubMed ID: 35505674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to: The long non-coding RNA
    Neurooncol Adv; 2023; 5(1):vdad051. PubMed ID: 37152807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
    Song AJ; Ding K; Alnahhas I; Laperriere NJ; Perry J; Mason WP; Winch C; O'Callaghan CJ; Menten JJ; Brandes AA; Phillips C; Fay MF; Nishikawa R; Osoba D; Cairncross JG; Roa W; Wick W; Shi W
    Neurooncol Adv; 2022; 4(1):vdac011. PubMed ID: 35098127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to: A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.
    Yogananda CGB; Shah BR; Yu FF; Pinho MC; Nalawade SS; Murugesan GK; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
    Neurooncol Adv; 2023; 5(1):vdac187. PubMed ID: 36632567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to: Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study.
    Neurooncol Adv; 2023; 5(1):vdad155. PubMed ID: 38077211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic transventricular biopsy in brainstem diffuse midline glioma: how I do it.
    La Corte E; Babini M; Bortoluzzi G; Zucchelli M
    Acta Neurochir (Wien); 2023 Apr; 165(4):1099-1103. PubMed ID: 36481874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to: Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
    Neurooncol Adv; 2023; 5(1):vdad114. PubMed ID: 37750101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient.
    Fujioka Y; Hata N; Hatae R; Suzuki SO; Sangatsuda Y; Nakahara Y; Mizoguchi M; Iihara K
    Neuropathology; 2020 Feb; 40(1):99-103. PubMed ID: 31762138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.